HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urinary angiotensinogen in pediatric urinary tract infection.

AbstractBACKGROUND:
Urinary tract infection (UTI) is one of the most common diseases in children, and urinary angiotensinogen (U-AGT) is a new biomarker gathering attention in many renal diseases. U-AGT reflects intrarenal renin-angiotensin system (RAS) activity. We conducted a study to measure U-AGT in children <4 months old with UTI.
METHODS:
All children <4 months old who came to Toshima Hospital with fever between January 2015 and December 2015 were included. Patients were divided into a UTI group and a non-UTI group, and U-AGT was measured.
RESULTS:
Median U-AGT was higher in patients with UTI compared with patients without UTI: (0.56 ng/dL, range, 0.025-2.753 ng/dL vs 0.13 ng/dL, range, 0.008-1.697 ng/dL, respectively; P < 0.05).
CONCLUSIONS:
U-AGT is elevated in UTI patients, and RAS activation may contribute to renal injury caused by UTI.
AuthorsReina Mayumi, Yayoi Murano, Reina Yokota, Akihiro Nakao, Nao Miyazaki, Taichi Hara, Akira Mizutani, Kuniyoshi Hayashi, Yumiko Sakurai, Hiromichi Shoji, Tomoyuki Nakazawa, Toshiaki Shimizu
JournalPediatrics international : official journal of the Japan Pediatric Society (Pediatr Int) Vol. 61 Issue 7 Pg. 712-714 (Jul 2019) ISSN: 1442-200X [Electronic] Australia
PMID31120634 (Publication Type: Clinical Trial, Journal Article)
Copyright© 2019 Japan Pediatric Society.
Chemical References
  • AGT protein, human
  • Biomarkers
  • Angiotensinogen
Topics
  • Angiotensinogen (urine)
  • Biomarkers (urine)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Prospective Studies
  • Urinary Tract Infections (diagnosis, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: